The expression of the sex steroids receptor and serum sex steroids status in uterine fibroids, endometriosis, and uterine adnomyosis

The expression of the sex steroids receptor and serum sex steroids status in uterine fibroids, endometriosis, and uterine adnomyosis - The sex steroids receptor expression in fibroids, endometriosis, and adnomyosis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014770

Enrollment

150

Registered

2014-08-06

Start date

2011-01-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine fibroma, endometriosis, uterine adenomyosis

Interventions

no prior treatments progestin therapy GnRHa therapy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: the patients with uetrine fibroma,who have received surgical treatments

Exclusion criteria

Exclusion criteria: under 20 years old, over 40, or post menopausal women

Design outcomes

Primary

Measure	Time frame
the quantification of expression levels of sex steroids receptors in legions obtained from specimens, and comparison of serum levels of sex steroids between diseases.	—

Countries

Japan

Contacts

Public ContactAtushi Hayashi

Osaka Medical College Obstetrics and Gynecology

gyn74@poh.osaka-med.ac.jp+81-72-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026